Treatment of Moderate to Severe Refractory Crohn's Disease
Status:
RECRUITING
Trial end date:
2026-12-15
Target enrollment:
Participant gender:
Summary
This research study is testing an investigational research product called TRX103 as a possible treatment for individuals suffering from Crohn's Disease (CD). The primary purpose of this study is to learn how safe and effective different doses of TRX103 are when administered to individuals with CD.